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Synopsis
The 67LR (67 kDa laminin receptor) enables cells to interact with components of the extracellular matrix. The molecule
is derived from the 37LRP (37 kDa laminin receptor precursor); however, the precise molecular mechanism of this
conversion is unknown. Recombinant 37LRP , expressed in and puriﬁed from Escherichia coli, bound to human laminin
in a SPR (surface plasmon resonance) experiment. 67LR isolated from human breast-cancer-derived cells in culture
was also shown to bind to laminin by SPR. However, the kinetics of association are qualitatively different. 37LRP , but
not 67LR, binds to heparan sulfate. The binding of 37LRP to heparan sulfate did not affect the interaction of 37LRP
with laminin. In contrast, heparan sulfate reduces the extent of binding of laminin to 67LR. Taken together, these
results show that 37LRP has some of the biological activities of 67LR, even prior to the conversion event. However,
the conversion affects the sites of interaction with both laminin and heparan sulfate.
Key words: heparan sulfate, 37 kDa laminin receptor precursor (37LRP), 67 kDa laminin receptor (67LR), laminin
receptor, ribosomal protein SA, surface plasmon resonance (SPR)
INTRODUCTION
In multicellular organisms, cells must be organized into tissues,
organs and other structures. In part, this organization is achieved
through interactions between cells and extracellular matrices.
Thus it follows that there must be receptors on the surfaces of
cells which recognize molecules in the extracellular matrix, bind
to that matrix and transduce signals to the interior of the cell.
Onesuchreceptoristhe67LR(67 kDalamininreceptor)[1].This
moleculehasattracted considerableinterestsinceitsdiscoveryin
1983[2–5],notleastbecauseofitswelldocumentedinvolvement
in the metastasis of cancerous cells [6,7].
The precise molecular nature of this receptor is a mystery.
It is now well established that it arises from a smaller poly-
peptide, the 37LRP (37 kDa laminin precursor). However, the
biochemical changes which accompany this alteration in mole-
cular mass are not known and there are a number of conﬂicting
hypotheses. These include homodimerization, heterodimeriza-
tion with an unidentiﬁed partner or fatty acylation [8–10]. Inter-
estingly, 37LRP not only acts as a precursor for 67LR, but also
functionsasaribosomalsubunit(knownasribosomalproteinSA
............................................................................................................................................................................................................................................................................................................
Abbreviations used: BCIP/NBT, 5-bromo-4-chloroindol-3-yl phosphate/Nitro Blue Tetrazolium; EDC, N-ethyl-N -(3-dimethylaminopropyl)carbodi-imide; IPTG, isopropyl β-D-thiogalactoside;
LB, Luria–Bertani; 37LRP , 37 kDa laminin receptor precursor; 67LR, 67 kDa laminin receptor; NHS, N-hydroxysuccinimide; RU, resonance unit(s); SPR, surface plasmon resonance;
TBS, Tris-buffered saline; TBST, TBS, pH 7.4, with 0.1% (v/v) Tween 20.
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or p40) [11–15] and as a nuclear protein where it interacts with
histones [16,17]. The ribosomal functions are conserved across
all kingdoms of life, with homologous proteins being found in
archea, eubacteria, fungi, plants and animals [1]. However, the
laminin receptor functions (and, presumably, the accompanying
alterations to the molecule) are unique to multicellular animals.
In addition to acting as a laminin receptor, 67LR acts as a re-
ceptor for the internalization of some viruses, prions and bacteria
[18–21].
The precise contact sites between 67LR and laminin have not
beenmapped.However,itisbelievedthattheinteractioninvolves
a nonapeptide from the β1 chain of laminin (CDPGYIGSR) and
residues 205–229 of human 67LR [22–24]. Additional contacts
maybeprovidedbyresidues161–180of67LR,theso-calledpep-
tideG[25].Residues205–229arepredictedtoadoptamainlyhel-
ical secondary structure, presenting two faces: a highly charged
polar heparan-sulfate-binding surface and a more hydrophobic
surface which interacts with laminin [22]. The functional con-
sequence of this is that laminin and heparan sulfate binding
are not mutually exclusive events at this site. The situation is
different with peptide G. Here, interaction with laminin and
the related sulfated glycoprotein heparin appear to be mutually
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Figure 1 Structure of human 37LRP
One of the proposed laminin-binding sites, peptide G (residues
161–180) is shown in black. The structure begins at residue 9 (Q9;
single-letter amino-acid code) and ﬁnishes at residue 205 (R205) (both
indicated on the Figure). Thus the structure lacks almost all the C-ter-
minal laminin-binding site, which starts at residue 205. The Figure was
produced using the co-ordinates from Protein Data Bank (PDB) ﬁle 3BCH
[27] and PyMOL (www.pymol.org).
exclusive [26]. Taken together, this suggests that heparan sulfate
(or heparin) binding to 67LR may reduce the afﬁnity of interac-
tionsbetween67LRandlaminin,butnotabolishthemaltogether.
Recently, the structure of a fragment of 37LRP was solved [27].
The structure shows a high degree of similarity to ribosomal
protein SA from prokaryotes and lower eukaryotes [28–30].
However, this structure (Figure 1) lacks the C-terminal region
(which is not present in lower organisms) and thus the bulk of the
main putative laminin-binding peptide. Peptide G forms part of a
β-strand, a loop and an α-helix, much of which is buried in the
interior of the molecule. Thus it has been postulated that con-
siderable conformational changes are required to enable laminin
binding [1].
The essential functions of 67LR combined with its key role
in a number of different disease processes has resulted in con-
siderable efforts to understand its structure and function. How-
ever, these have been hampered by lack of understanding of
how 37LRP and 67LR differ. In the present study we expressed
37LRP in the bacterium Escherichia coli, taking advantage of
the lack of post-translational modiﬁcations in the organism to
ensure that we isolated the unmodiﬁed precursor, and compared
the ability of this protein to interact with laminin of that of 67LR
which was shed from human breast-cancer-derived T47D cells in
culture.
MATERIALS AND METHODS
Expression and puriﬁcation of recombinant 37LRP
in E. coli
A cDNA IMAGE clone [31] (Clone ID 4820432; Geneservice,
Cambridge, U.K.) containing the coding sequence for human
37LRP was used as a PCR template. The ampliﬁed product was
inserted into pET-46 Ek/LIC (Merck, Nottingham, U.K.) using
theligation-independentcloningprotocolaccordingtothemanu-
facturer’s instructions. Correctly assembled expression plasmids
were identiﬁed by restriction digestion and DNA sequencing
(MWG Biotech, Ebersford, Germany) of the entire coding se-
quence.
The expression vector was transformed into E. coli
HMS174(DE3) cells (Merck). Single colonies were used to in-
oculate 5-ml cultures in LB (Luria–Bertani) broth (Miller) sup-
plemented with 100 μg·ml−1 ampicillin. These cultures were
grown, with shaking at 37◦C overnight, and then diluted into
1 l of LB broth (supplemented with 100 μg·ml−1 ampicillin).
This culture was grown, with shaking at 37◦C, until the D600
reached between 0.6 and 1.0 (typically 3–4 h), then induced with
1 mM IPTG (isopropyl β-D-thiogalactoside) and grown for a
further 2 h. At this point, the cells were harvested by centrifu-
gation at 4200 g, resuspended in approx. 20 ml of cell resuspen-
sion buffer [50 mM Hepes-OH, pH 7.5, 150 mM sodium chlor-
ide and 10% (v/v) glycerol] and stored, frozen at −80◦C, until
required.
These cell suspensions were thawed and guanidine hydro-
chloride was added to a ﬁnal concentration of 6 M. The cells
were disrupted by sonication (three times 30 s pulses at 100 W
with 30–60 s gaps between pulses for cooling). Cell debris was
then removed by centrifugation (24000 g for 15 min at 4◦C) and
the supernatant immediately applied to a 1 ml nickel–agarose
column(His-Select;Sigma,Poole,Dorset,U.K.),whichhadbeen
previously equilibrated in buffer A [50 mM Hepes-OH, pH 7.5,
500 mMsodiumchloride,6 Mguanidinehydrochlorideand10%
(v/v) glycerol]. The supernatant was allowed to ﬂow through by
gravity and the column was then washed with 20 ml of buffer
A, followed by 20 ml of buffer B (buffer A without guanid-
ine hydrochloride). Elution was achieved by application of three
2 ml aliquots of buffer C (buffer B supplemented with 250 mM
imidazole). These aliquots were collected as separate fractions.
Protein containing fractions were identiﬁed by SDS/PAGE (10%
gels) in Tris/glycine buffer (pH 8.3), dialysed against cell resus-
pensionbuffersupplementedwith2 mMDTT(dithiothreitol)and
frozen in small aliquots at −80◦C.
Puriﬁcation of native 67LR
67LR was obtained from T47D human breast carcinoma cells
(European Collection of Cell Cultures, Porton Down, Salisbury,
U.K.). This cell line sheds the receptor into the medium on ro-
tational incubation [32]. The cells were cultured in high-glucose
DMEM (Dulbecco’s modiﬁed Eagle’s medium), with glutam-
ine and sodium pyruvate (PAA, Pasching, Austria). The cul-
tures were harvested (at 70–75% conﬂuence) by washing the
monolayer with calcium-free saline and incubating the mono-
layer for 15 min with cell dissociation ﬂuid (Sigma). The cells
werethencentrifugedat800 gfor10 min.Thecellpellet(approx
1.5×107 cells) was resuspended in 500 μl of ice-cold PBS and
incubated with rotation at 37◦C for 2 h. The crude preparation of
shed receptor was obtained by centrifuging the cells at 16000 g
at 4◦C for 10 min. The supernatant was aliquoted and stored
at −80◦C. Protein concentration was estimated using the BCA
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(bicinchoninic acid) protein assay kit (Pierce, Rockford, IL,
U.S.A.) in microtitre plates.
Western blotting
37LRP and 67LR were run on 10–20% pre-cast Tricine gels (In-
vitrogen, Paisley, Renfrewshire, U.K.) under denaturing condi-
tions using TCEP [Tris(2-carboxyethyl)phosphine] (Sigma) as
a reducing agent at a ﬁnal concentration of 5 mM. Follow-
ing electrophoresis (at 200 V), transfer of the proteins on to
a nitrocellulose membrane was carried out using an XCell II
MiniBlot apparatus (Novex) at 30 V for 1 h. The membrane was
then washed in TBST [TBS (Tris-buffered saline), pH 7.4, with
0.1% (v/v) Tween 20]. The membrane was blocked with 2%
(w/v) non-fat dried milk in TBST for 30 min. The membrane
was washed and the primary antibody was diluted 1:1000 in
2% (w/v) non-fat dried milk in TBST overnight. The two anti-
bodies used were Pro-20-Ala (a polyclonal antibody raised
against a 20 residue peptide from the C-terminus of 67LR)
and Ab183 (67LR N-terminal-speciﬁc antibody) [33,34]. The
membranes were washed with TBST and secondary anti-rabbit
alkaline-phosphatase-conjugated antibody (Sigma) was applied
to the membrane in a 1:4000 dilution for 1 h. The membrane was
washed with TBS and a BCIP/NBT (5-bromo-4-chloroindol-3-
yl phosphate/Nitro Blue Tetrazolium) substrate was prepared by
dissolving one tablet of Fast BCIP/NBT (Sigma) in 10 ml of de-
ionized water and adding it to the membranes for 10 min. Colour
development was stopped using de-ionized water.
SPR (surface plasmon resonance)
All experiments were carried out using a BIAcore 3000
biosensor (GE Healthcare, Uppsala, Sweden). Recombinant
37LRP and native 67LR were immobilized using NHS/EDC
[N-hydroxysuccinimide/N-ethyl-N -(3-dimethylaminopropyl)-
carbodi-imide] coupling, followed by blocking with ethanolam-
ine [35,36]. Two different sets of immobilizations were carried
out using 67LR and 37LRP. Both proteins were concentrated
in 10 mM acetate buffer (pH 4.0) using YM-3 membrane ﬁlters
(Microcon). All solutions (made ‘in house’) were ﬁltered before
use. Activation was done using 150 μl of 100 mM NHS/390 mM
EDC for 30 min at 5 μl·min−1; immobilization was carried
out with a 50 μl injection of the desired protein for 10 min at
5 μl·min−1, followed by a 30 min blocking step with 150 μl
of 1 M ethanolamine at 5 μl·min−1. The 37LRP was immob-
ilized on lane 2 and the 67LR was immobilized on lane 4 of
the same chip. Lanes 1 and 3 served as control lanes, so that
any non-speciﬁc binding that occurred with the cross-linkers,
rather than the protein, could be subtracted from the ﬁnal RU
(resonance units) in the experimental lane. These lanes were sub-
jected to the same NHS/EDC activation followed by blocking
with ethanolamine as the experimental lanes. Data were ana-
lysed using BIAevaluation software (GE Healthcare), applying
the1:1Langmuir-bindingmodel,accordingtothemanufacturer’s
instructions.
Before the start of any binding assay, a regeneration step was
carried out using NaOH (5–50 mM, pH 10.0–12.6) to remove
any bound proteins and to obtain a stable baseline. The assays
were all carried out with a ﬁnal ligand injection volume of 50 μl
and a dissociation time of 300 s, using the KINJECT program
(GE Healthcare). Assays were carried out using mouse and hu-
man laminin (Sigma), heparan sulfate (Sigma) and the laminin
nonapeptide(PeptideSynthesisService,Queen’sUniversity,Bel-
fast, U.K.). All ligands were dissolved in 10 mM Hepes-OH,
pH 7.4, 150 mM NaCl, 3 mM EDTA and 0.005% (v/v) Tween 20
(HBS-EP; GE Healthcare). Data were visualized and analysed
using BIAevaluation software (GE Healthcare).
RESULTS
Soluble recombinant 37LRP can be puriﬁed
from E. coli
Initial attempts to purify recombinant 37LRP under native con-
ditions using protocols similar to those employed for human
S100B expressed using the same vector [37] were not success-
ful. Examination of SDS/PAGE gels showed that an additional
protein of approx. 35 kDa was present in E. coli whole-cell ex-
tracts following induction with IPTG, but that this protein was
not present in the soluble extract following sonication and cent-
rifugation (results not shown). This suggested that, although the
protein was expressed, the molecules formed insoluble aggreg-
ates in the E. coli cytoplasm. To overcome this problem, the cells
were sonicated and applied to the nickel-afﬁnity column in the
presenceofthestrongdenaturingagentguanidinehydrochloride.
Renaturation was achieved on the column by washing the bound
protein withbuffer lacking thedenaturing agent, and solublepro-
tein could be eluted by the addition of imidazole to the column
buffer (Figure 2a). Typical yields of soluble 37LRP were 2 mg
perlitreofculture.Thisrecombinantproteincouldberecognized
in Western blots by the antibody Ab183, but not the Pro-20-Ala
antibody, which only recognized mature 67LR (Figure 2b).
Human 37LRP and 67LR both interact with laminin
The high level of protein immobilized on the sensor chip com-
bined with the large molecular mass of laminin (approx. 900 kDa
[38])meanthatmasstransportislikelytobeastrongfeatureinthe
interaction kinetics, as measured by SPR. Consequently, the res-
ults can be regarded, at best, as semi-quantitative. Nevertheless,
interactions between human laminin and both 37LRP and 67LR
could be detected by SPR measurements (Figure 3). Estimation
of the dissociation constants (Kd) for the 37LRP–laminin and
67LR–laminin interactions yielded similar values (410 nM
and 320 nM respectively), suggesting similar overall afﬁnities.
Qualitativelythetwointeractioncurveslookdifferent,with67LR
exhibitingatleasttwophasesofassociation:aninitialrapidphase
which gives way to a slower one. In contrast, 37LRP appears to
have a single phase of association which is similar to the second,
slower phase observed with 67LR. Mouse laminin also interac-
ted with both 37LRP and 67LR, albeit to a lesser extent (results
not shown).
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Figure 2 Expression and puriﬁcation of recombinant 37LRP
(a) SDS/PAGE (Tris/glycine, pH 8.3, buffer) 10% gel stained with Coomassie Blue showing cell extract prior to induction
(U), cell extract 2 h post-induction (I), and samples from three 2 ml fractions following elution with 250 mM imidazole
(E). The puriﬁed, soluble 37LRP appeared largely in the second and third elution fractions and is indicated by an arrow.
(b) 67LR and 37LRP were resolved on 10–20% Tricine-gradient gels and Western blotted on to nitrocellulose. The antibody
Pro-20-Ala only recognizes 67LR, whereas the antibody Ab183 recognizes 37LRP . In the 67LR fraction, it recognizes a
protein which is slightly larger than 37LRP , which may be a partially processed form of 37LRP or a non-speciﬁcally bound
contaminant. In addition, a number of unidentiﬁed contaminating proteins in the 37LRP fraction are also recognized. Note
that different gel and buffer systems were used in the SDS/PAGE and Western blotting, resulting in slight differences in
the mobilities of the proteins. Arrows indicate the bands corresponding to 37LRP and 67LR. The sizes (in kDa) of the
molecular-mass markers (M) are shown.
Figure 3 An interaction between recombinant human 37LRP
and native human 67LR with laminin can be demonstrated
by SPR
In (a) 37LRP was immobilized on to a sensor chip surface, and laminin
at various concentrations (as indicated) was passed over the surface.
The graphs represent the difference in RU between a lane on the sensor
chip in which 37LRP has been immobilized and a control lane in which
no protein has been immobilized. In (b) the difference between a lane
in which 67LR had been immobilized and the control is shown. In both
(a) and (b), the data were analysed (using BIAevaluation software) to
derive dissociation constants (Kd) from the ratio of the dissociation
and association rate constants. The Kd for the 37LRP–laminin interac-
tion was estimated to be 410 nM and the value for the 67LR–laminin
interaction to be 320 nM. Note that these values should be treated
with caution, given likely mass-transport complications and the com-
plex nature of the 67LR–laminin interaction.
37LRP interacts with heparan sulfate, but 67LR
does not
When heparan sulfate (0.2 mg·ml−1) was passed over immob-
ilized 37LRP, an interaction was clearly detected (Figure 4a,
panel i). Binding to the laminin nonapeptide could not be de-
tected by SPR (but it should be noted that the response change
to this much smaller molecule would be reduced compared with
those observed with laminin). This peptide caused little or no
change to the binding of heparan sulfate. Interestingly, no inter-
action between 67LR and heparan sulfate could be detected, nor
could any interaction be detected with the laminin nonapeptide
or a mixture of heparan and nonapeptide (Figure 4a, panel ii).
The binding of laminin and heparan sulfate to 37LRP were
not mutually exclusive; the responses observed with mixtures of
these molecules were essentially the sum of responses seen with
the individual molecules at the same concentrations (Figure 4b,
panel i). This is not the case with 67LR, where heparan sulfate
reduces the binding of laminin (Figure 4b, panel ii).
DISCUSSION
It has been demonstrated previously that intact 37LRP is insol-
uble upon expression in bacteria [39]. Two solutions have been
pursued to address this problem. In one, a complex puriﬁca-
tion procedure involving the isolation of exclusion bodies and
their solubilization in urea resulted in puriﬁed soluble 37LRP
[39]. In the second approach, used to obtain the structure of
37LRP, a truncated form of the protein was expressed, which
proved to be soluble. On puriﬁcation, this protein could be crys-
tallized [27]. In the present study, we demonstrated a simpler and
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Figure 4 Interactions of 37LRP and 67LR with heparan sulfate
(a, panel i) An interaction between recombinant human 37LRP (immobilized) and heparan sulfate (Hep, continuous
line, soluble phase, 0.2 mg·ml−1) can be demonstrated by SPR. In contrast, no interaction could be detected between
37LRP and the laminin nonapeptide (Lam, dashed line, soluble phase, 100 μM), nor does this peptide greatly affect
the heparan–37LRP interaction (Hep+Lam, dotted line). (a, panel ii) No interaction could be detected between 67LR
(immobilized) and heparan sulfate (soluble phase, 0.2 mg·ml−1), laminin nonapeptide (soluble phase, 100 μM) or a
mixture of the two molecules. (b, panel i) Heparan and laminin interactions with 37LRP are not mutually exclusive.
The results observed (Hep+Lam, dotted line) with a mixture of heparan sulfate (soluble phase, 0.2 mg·ml−1) and mouse
laminin (soluble phase, 250 nM) are essentially the sum of the responses observed with heparan sulfate (Hep, continuous
line) and mouse laminin (Lam, dashed line) individually at the same concentrations. Similar results were observed with
human laminin (results not shown). (b, panel ii) Heparan sulfate (soluble phase, 0.2 mg·ml−1) reduces the extent of
interaction between mouse laminin (soluble phase, 200 nM) and 67LR (immobilized).
faster method for obtaining puriﬁed soluble full-length 37LRP.
Our method couples total denaturation of the E. coli proteins,
extraction of the His-tagged 37LRP by afﬁnity chromatography
and renaturation of protein on the column prior to elution. The
protein can be puriﬁed from bacterial cells in less than 1 day and
yields material with biological activity, as shown by its interac-
tions with an antibody in Western blotting and with laminin and
heparan sulfate in SPR experiments.
This interaction between 37LRP and these ligands is interest-
ing, as it infers that the processing of 37LRP to 67LR is not re-
quiredfortheproteintointeractwiththem.Ithasbeenspeculated
that the C-terminal region of 37LRP/67LR (which is not present
in the prokaryotic and lower eukaryotic ribosomal proteins) is at
least partly responsible for interaction with these ligands [1]. Our
observations are consistent with that hypothesis. Although we
wereabletodetectinteractionsbetweenlamininandboth37LRP
and 67LR, the qualitative differences between the binding curves
suggests differences in the molecular mechanisms of interaction.
These differences may arise due to intrinsic differences between
thetwomolecules.Indeed,if67LRresultsfromdimerization[9],
there would be two laminin-binding sites, possibly with different
afﬁnities. Alternatively, it is possible that heterogeneity of the
67LR preparation (which, potentially, includes some unmodiﬁed
37LRPandintermediatestagesbetweenthetwoforms)givesrise
tothemultiphasicnatureoftheassociationkinetics.Thusitseems
likely that the modiﬁcations resulting in maturation of 37LRP to
67LR directly, or indirectly, affect the sites of interaction with
laminin.
Thatbothheparansulfateandlaminincaninteractwith37LRP
simultaneously suggest that the two molecules bind at different
sites and that there is limited (or no) allosteric communication
between these sites. Since both laminin and heparan sulfate are
extracellular molecules, we assume that 37LRP does not interact
with these ligands in vivo. In these experiments, we were unable
todetectinteractionsbetween67LRandheparansulfate,suggest-
ing that processing of 37LRP abolishes this activity. It should be
noted that immobilized heparin is often used to purify nucleic-
acid-binding proteins. Therefore, it is possible that the interac-
tion between 37LRP and heparan sulfate may reﬂect the well-
documented interactions of the molecule with nucleic acids [40].
Furthermore,heparansulfateappearstoinhibitthe67LR–laminin
interaction. It has been shown that the related polysaccharide,
heparin, also inhibits 67LR–laminin interactions, and it was sug-
gestedthatthisiscausedbythepolysaccharidecompetingforthe
67LR-binding site on laminin [26]. A similar mechanism may be
occurring here. If it is, then 37LRP may interact, at least in part,
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at a separate site on laminin, which is not affected by heparan
sulfate competition.
Overall, the results of the present study demonstrate that
37LRP has at least some of the biological activities of 67LR,
even prior to processing. However, the processing events modify
these biological activities. Thus they also further underline the
need to understand this processing event at the molecular level.
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